article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

Participants had no history of heart failure but had at least one heart failure risk factor in addition to signs of potential heart dysfunction as indicated by a newly lowered left ventricle ejection fraction to below 45% and/or signs or symptoms of congestion requiring treatment. About 32% had Type 2 diabetes.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

Participants had no history of heart failure but had at least one heart failure risk factor in addition to signs of potential heart dysfunction as indicated by a newly lowered left ventricle ejection fraction to below 45% and/or signs or symptoms of congestion requiring treatment. About 32% had Type 2 diabetes.

article thumbnail

The latest CDC paper on vaccine myocarditis is NOT reassuring

Dr. Anish Koka

Today’s post on the latest COVID vaccine myocarditis paper gets a big assist from the wicked smart data visualization expert Josh Stevenson ( subscribe to his substack !) In August 2021, the CDC began a study to follow-up cases of myocarditis in the age group at highest risk for myocarditis after mRNA COVID-19 vaccination.